Newsroom

LONDRES--(BUSINESS WIRE)--Pleo, la plateforme européenne de référence en matière de finance stratégique, annonce aujourd'hui le lancement d'une suite d'agents IA capables de gérer de manière autonome les dépenses courantes, permettant ainsi aux responsables financiers de se concentrer sur la prise de décision plutôt que sur les tâches administratives. Les équipes financières subissent une pression croissante : 45 % des entreprises européennes affirment que leurs processus actuels les ralentisse...

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on June 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 32,000 shares of its common stock. These inducement RSUs are subject to the terms of Travere’s 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as i...

ARLINGTON, Va.--(BUSINESS WIRE)--Venture Global Announces Closing of $2.25 Billion of Senior Secured Notes...

LOS ANGELES--(BUSINESS WIRE)--Remedy Science (“REMEDY”), the dermatologist-developed, education-first skincare brand translating clinical expertise into accessible, high-performance products, today announced the closing of its Series A funding round led by L Catterton, the largest global consumer-focused investment firm, with participation from existing investor Norwest and new investor Sonoma Brands Capital. Founded by board-certified dermatologist Dr. Muneeb Shah, REMEDY was created to mirror...

LONDEN--(BUSINESS WIRE)--Pleo, Europa's eerste en meest vertrouwde platform voor strategische finance, kondigde vandaag een reeks AI agents aan die routine uitgavenbeheer autonoom afhandelen, zodat finance leiders hun aandacht kunnen toespitsen op beslissingen in plaats van hun tijd aan administratieve taken te besteden. Finance teams staan steeds meer onder druk: 45% van de Europese bedrijven geeft aan dat hun huidige processen hen afremmen, en leiders beschrijven goedkeuringsworkflows als zo...

LONDON--(BUSINESS WIRE)--Pleo, Europas erste und vertrauenswürdigste Plattform für strategisches Finanzmanagement, präsentiert heute mehrere KI-Agenten, die das routinemäßige Ausgabenmanagement selbstständig durchführen, damit Finanzverantwortliche ihren Fokus auf wichtige Entscheidungen statt auf administrative Aufgaben legen können. Finanzteams sind einem wachsenden Druck ausgesetzt: 45 % der europäischen Unternehmen fühlen sich durch ihre derzeitigen Prozesse ausgebremst. Führungskräfte betr...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Yum! Brands, Inc. to Participate in the NYSE European Investor Conference in Association With Bank of America...

VICTOR, N.Y.--(BUSINESS WIRE)--Broadstone Net Lease Adds $40 million to its Committed Pipeline of Build-to-Suit Developments...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Long-Term Issue Credit Rating (Long-Term IR) of “a” (Excellent) on the $846 million (of which $407 million remained outstanding as of March 31, 2026), 6.00% Series Hannover, No. 1 variable funding credit-linked note (Block 1 CLN), due July 1, 2038, issued by Weston2038 LLC (Weston2038), a Delaware limited liability company (issuer). Concurrently, AM Best has affirmed the Long-Term IR of “a” (Excellent) on the $433 million (which upsized to...

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, announced that today the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance with respect to U.S. Patent Application No. 17/151,405, entitled “Compositions and Methods of Use.” The a...